‘PfizerGan’ Going Strong In India But Tweaks In Store?
This article was originally published in PharmAsia News
Executive Summary
Pfizer and Allergan have reported strong individual growth on the Indian market recently but their $160bn global merger does little to bolster the combination's ranking on the Indian market.